Clinical Trials · NCT02690883
Effect of Exenatide on 24h-UAER in Patients With Diabetic Nephropathy
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Nanfang Hospital, Southern Medical University
- Enrollment
- 92
- Start date
- Apr 2016
- Locations
- See registry
- Primary endpoint
- the percentage change of 24h-UAER(urinary albumin excretion rates) from baseline at Week 24